Long-term survival of childhood coronary artery disease in a patient severely affected with familial hypercholesterolemia.
This brief account of a patient severely affected with familial hypercholesterolemia and with coronary artery disease since age 13 reviews his therapy and survival into the fifth decade of life. This is heretofore unreported in phenotypically homozygous patients with familial hypercholesterolemia in the era before statin drugs, low-density lipoprotein apheresis, or their combination.
Sibley
Christopher
C
Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
McGann
Sarah
S
Stone
Neil J
NJ
D000328:Adult; D000367:Age Factors; D001781:Blood Component Removal / Q000379:methods; D001026:Coronary Artery Bypass / Q000379:methods; D003324:Coronary Artery Disease / Q000209:etiology / Q000628:therapy*; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000150:complications / Q000235:genetics* / Q000628:therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008297:Male; D009765:Obesity / Q000150:complications; D010375:Pedigree; D012720:Severity of Illness Index; D017741:Survivors; D016896:Treatment Outcome
D000960:Hypolipidemic Agents